Regulatory Rapporteur November 2013

<< back to list of Issues

Front Cover
Volume 10 Issue 11

In This Issue

  • FOCUS: US Update
  • PLUS
  • Medical devices: Proposed new biocompatibility testing strategies under the spotlight
  • The advantages of change management protocols

Please login to view member only articles. Non-members may download the public articles.

Regulatory Rapporteur November 2013MembersFull Issue3MBPDF
Editorial: creating a safer America for patientsPublic56KBPDF
The reality of regulatory leaders in pharma todayPublic174KBPDF
Biocompatibility testing for medical devices – trouble ahead?Members130KBPDF
Experiences with post-approval change management protocolsMembers112KBPDF
FDASIA and the orphans - does the new US law affect therapies for rare diseases?Members237KBPDF
Global label harmonisation: A compliance challenge worth meetingMembers226KBPDF
Insight into the Rutgers Pharmaceutical Industry Fellowship ProgramMembers96KBPDF
Keeping it real - the fight again counterfeit medicines in the USMembers110KBPDF
The GAIN Act: Facilitating antibiotic drug developmentMembers164KBPDF